Trial · NCT00928408
Registered outcomes26
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 26
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cinacalcet Dose | Initiation of treatment | Cinacalcet dose at initiation of treatment |
| Primary | Cinacalcet Dose | Month 3 | Cinacalcet dose at Month 3 |
| Primary | Cinacalcet Dose | Month 6 | Cinacalcet dose at Month 6 |
| Primary | Cinacalcet Dose | Month 12 | Cinacalcet dose at Month 12 |
| Primary | Cinacalcet Dose | Up to Month 12 | Cinacalcet dose at end of treatment (last dose received) |
| Primary | Cinacalcet Dosing Frequency | Initiation of treatment | Cinacalcet dosing frequency at initiation of treatment |
| Primary | Cinacalcet Dosing Frequency | Month 3 | Cinacalcet dosing frequency at Month 3 |
| Primary | Cinacalcet Dosing Frequency | Month 6 | Cinacalcet dosing frequency at Month 6 |
| Primary | Cinacalcet Dosing Frequency | Month 12 | Cinacalcet dosing frequency at Month 12 |
| Primary | Cinacalcet Dosing Frequency | Up to Month 12 | Cinacalcet dosing frequency at end of treatment |
| Primary | Occurrence of a Change in Cinacalcet Dose or Frequency During the First 3 Months After Initiation | Initiation to Month 3 | |
| Primary | Occurrence of a Change in Cinacalcet Dose or Frequency >3 to 6 Months After Initiation | >3 to 6 months after initiation | |
| Primary | Occurrence of a Change in Cinacalcet Dose or Frequency >6 Months After Initiation | >6 months after initiation | |
| Primary | Duration of Exposure to Cinacalcet | 12 months | Time from first dose to last non-zero dose on study |
| Primary | Achievement of a Reduction From Baseline of Albumin-corrected Serum Calcium ≥ 0.25 mmol/L (1 mg/dL) at Month 3 | Month 3 | Baseline is pre-cinacalcet. |
| Primary | Achievement of a Reduction From Baseline of Albumin-corrected Serum Calcium ≥ 0.25 mmol/L (1 mg/dL) at Month 6 | Month 6 | Baseline is pre-cinacalcet. |
| Primary | Achievement of a Reduction From Baseline of Albumin-corrected Serum Calcium ≥ 0.25 mmol/L (1 mg/dL) at Month 12 | Month 12 | Baseline is pre-cinacalcet. |
| Primary | Incidence of an Albumin-corrected Serum Calcium Concentration ≤ 2.6 mmol/L (10.3 mg/dL) at Month 3 | Month 3 | |
| Primary | Incidence of an Albumin-corrected Serum Calcium Concentration ≤ 2.6 mmol/L (10.3 mg/dL) at Month 6 | Month 6 | |
| Primary | Incidence of an Albumin-corrected Serum Calcium Concentration ≤ 2.6 mmol/L (10.3 mg/dL) at Month 12 | Month 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00928408/registered